106 related articles for article (PubMed ID: 1393930)
1. Economic impact of HIV infection and coronary heart disease in immigrants to Canada.
Zowall H; Coupal L; Fraser RD; Gilmore N; Deutsch A; Grover SA
CMAJ; 1992 Oct; 147(8):1163-72. PubMed ID: 1393930
[TBL] [Abstract][Full Text] [Related]
2. HIV antibody screening among immigrants: a cost-benefit analysis.
Zowall H; Fraser RD; Gilmore N; Deutsch A; Grover S
CMAJ; 1990 Jul; 143(2):101-7. PubMed ID: 2114210
[TBL] [Abstract][Full Text] [Related]
3. [Socioeconomic aspects of human immunodeficiency virus (HIV) infection in developing countries].
Gentilini M; Chieze F
Bull Acad Natl Med; 1990 Nov; 174(8):1209-19; discussion 1219-21. PubMed ID: 2094555
[TBL] [Abstract][Full Text] [Related]
4. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
Whitfield MD; Gillett M; Holmes M; Ogden E
Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
[TBL] [Abstract][Full Text] [Related]
5. Coronary heart disease risks in first- and second-generation immigrants in Sweden: a follow-up study.
Sundquist K; Li X
J Intern Med; 2006 Apr; 259(4):418-27. PubMed ID: 16594910
[TBL] [Abstract][Full Text] [Related]
6. Economic consequences of HIV/AIDS in India.
Pandav CS; Anand K; Shamanna BR; Chowdhury S; Nath LM
Natl Med J India; 1997; 10(1):27-30. PubMed ID: 9069706
[TBL] [Abstract][Full Text] [Related]
7. The five-year impact of an evolving global epidemic, changing migration patterns, and policy changes in a regional Canadian HIV population.
Krentz H; Gill MJ
Health Policy; 2009 May; 90(2-3):296-302. PubMed ID: 19022519
[TBL] [Abstract][Full Text] [Related]
8. The cost of obesity in Canada.
Birmingham CL; Muller JL; Palepu A; Spinelli JJ; Anis AH
CMAJ; 1999 Feb; 160(4):483-8. PubMed ID: 10081464
[TBL] [Abstract][Full Text] [Related]
9. Preventing perinatal transmission of HIV--costs and effectiveness of a recommended intervention.
Gorsky RD; Farnham PG; Straus WL; Caldwell B; Holtgrave DR; Simonds RJ; Rogers MF; Guinan ME
Public Health Rep; 1996; 111(4):335-41. PubMed ID: 8711101
[TBL] [Abstract][Full Text] [Related]
10. Needle exchange programs: an economic evaluation of a local experience.
Gold M; Gafni A; Nelligan P; Millson P
CMAJ; 1997 Aug; 157(3):255-62. PubMed ID: 9269195
[TBL] [Abstract][Full Text] [Related]
11. Direct and indirect costs of asthma in Canada, 1990.
Krahn MD; Berka C; Langlois P; Detsky AS
CMAJ; 1996 Mar; 154(6):821-31. PubMed ID: 8634960
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of simvastatin in the secondary prevention of coronary artery disease in Canada.
Rivière M; Wang S; Leclerc C; Fitzsimon C; Tretiak R
CMAJ; 1997 Apr; 156(7):991-7. PubMed ID: 9099167
[TBL] [Abstract][Full Text] [Related]
13. [The costs of treating HIV-infected children in Abidjan, Ivory Coast, 1996-1997].
Giraudon I; Leroy V; Msellati P; Elenga N; Ramon R; Welffens-Ekra C; Dabis F
Sante; 1999; 9(5):277-81. PubMed ID: 10657769
[TBL] [Abstract][Full Text] [Related]
14. Economic analysis of treatments reducing coronary heart disease mortality in England and Wales, 2000-2010.
Fidan D; Unal B; Critchley J; Capewell S
QJM; 2007 May; 100(5):277-89. PubMed ID: 17449875
[TBL] [Abstract][Full Text] [Related]
15. HIV infection among women undergoing abortion in Montreal.
Remis RS; Eason EL; Palmer RW; Najjar M; Leclerc P; Lebel F; Fauvel M
CMAJ; 1995 Nov; 153(9):1271-9. PubMed ID: 7497389
[TBL] [Abstract][Full Text] [Related]
16. Serological markers for hepatitis B and treponemal infection among HIV carriers from Ethiopia.
Alkan ML; Maayan S; Belmaker I; Arbeli Y; Mani N; Ben-Yshai F
Isr J Med Sci; 1993; 29(6-7):390-2. PubMed ID: 8349459
[TBL] [Abstract][Full Text] [Related]
17. Impact of rosuvastatin use on costs and outcomes in patients at high risk for cardiovascular disease in US managed care and medicare populations: A data analysis.
Huse DM; Song X; Ozminkowski RJ; Maguire J; Williams SA; Borok GM; McDonough K
Clin Ther; 2006 Sep; 28(9):1425-42. PubMed ID: 17062315
[TBL] [Abstract][Full Text] [Related]
18. Screening for hypercholesterolemia among Canadians: how much will it cost?
Grover SA; Coupal L; Fahkry R; Suissa S
CMAJ; 1991 Jan; 144(2):161-8. PubMed ID: 1986828
[TBL] [Abstract][Full Text] [Related]
19. Forecasting the medical care costs of the HIV epidemic: 1991-1994.
Hellinger FJ
Inquiry; 1991; 28(3):213-25. PubMed ID: 1833332
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV.
Pinkerton SD; Holtgrave DR; Pinkerton HJ
Arch Intern Med; 1997 Sep; 157(17):1972-80. PubMed ID: 9308509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
